[
  {
    "ts": null,
    "headline": "Is Boston Scientific's Valuation Justified After 18% Gain and New Product Launches?",
    "summary": "Ever wondered if Boston Scientific is a bargain or if the run-up has left it looking pricey? Let’s dig into what’s driving its value right now. Shares have gained 2.7% in the past week and are up 18.0% over the last year, with a huge 139.0% return in three years. This hints at both solid growth and changing investor sentiment. Much of this momentum is being fueled by Boston Scientific’s recent product launches and its acquisition strategy, which have drawn industry attention and optimism...",
    "url": "https://finnhub.io/api/news?id=9cbd9adb8e6ff6cdbd2d3b9380c7201552beaeea5a96e3f1c22d4a8f6d2c92f2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763269842,
      "headline": "Is Boston Scientific's Valuation Justified After 18% Gain and New Product Launches?",
      "id": 137494722,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Ever wondered if Boston Scientific is a bargain or if the run-up has left it looking pricey? Let’s dig into what’s driving its value right now. Shares have gained 2.7% in the past week and are up 18.0% over the last year, with a huge 139.0% return in three years. This hints at both solid growth and changing investor sentiment. Much of this momentum is being fueled by Boston Scientific’s recent product launches and its acquisition strategy, which have drawn industry attention and optimism...",
      "url": "https://finnhub.io/api/news?id=9cbd9adb8e6ff6cdbd2d3b9380c7201552beaeea5a96e3f1c22d4a8f6d2c92f2"
    }
  },
  {
    "ts": null,
    "headline": "What Boston Scientific (BSX)'s Surging Sales and Siemens Partnership Mean for Shareholders",
    "summary": "Boston Scientific recently reported strong quarterly results, surpassing expectations with 21.4% organic sales growth and raising its full-year 2025 outlook for both revenue and adjusted earnings per share. The company also announced an exclusive distribution agreement for the AcuNav 4D ICE catheter with Siemens Healthineers, aimed at supporting the expansion of its Watchman business and procedural adoption. We'll examine how Boston Scientific's improved financial outlook and new partnership...",
    "url": "https://finnhub.io/api/news?id=d74303326bc7325f71c1ddc8a133db55b49e2cb062bcc23c8a447b9d27731dad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763255131,
      "headline": "What Boston Scientific (BSX)'s Surging Sales and Siemens Partnership Mean for Shareholders",
      "id": 137494723,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific recently reported strong quarterly results, surpassing expectations with 21.4% organic sales growth and raising its full-year 2025 outlook for both revenue and adjusted earnings per share. The company also announced an exclusive distribution agreement for the AcuNav 4D ICE catheter with Siemens Healthineers, aimed at supporting the expansion of its Watchman business and procedural adoption. We'll examine how Boston Scientific's improved financial outlook and new partnership...",
      "url": "https://finnhub.io/api/news?id=d74303326bc7325f71c1ddc8a133db55b49e2cb062bcc23c8a447b9d27731dad"
    }
  }
]